BA
UTHR icon

BlackRock Advisors’s United Therapeutics UTHR Stock Holding History

BlackRock Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$25.1M Buy
175,318
+14,572
+9% +$1.86M 0.03% 473
2016
Q3 		$19M Buy
160,746
+77,486
+93% +$9.31M 0.02% 555
2016
Q2 		$8.82M Sell
83,260
-257,343
-76% -$28.7M 0.01% 882
2016
Q1 		$38M Sell
340,603
-1,020,796
-75% -$129M 0.04% 373
2015
Q4 		$213M Sell
1,361,399
-71,933
-5% -$10.5M 0.23% 113
2015
Q3 		$188M Buy
1,433,332
+3,864
+0.3% +$620K 0.2% 122
2015
Q2 		$249M Sell
1,429,468
-216,944
-13% -$39M 0.26% 103
2015
Q1 		$284M Sell
1,646,412
-33,505
-2% -$5.11M 0.29% 87
2014
Q4 		$218M Sell
1,679,917
-88,106
-5% -$11.4M 0.22% 117
2014
Q3 		$227M Buy
1,768,023
+580,992
+49% +$59.9M 0.23% 111
2014
Q2 		$105M Sell
1,187,031
-457,334
-28% -$44M 0.1% 221
2014
Q1 		$155M Buy
1,644,365
+51,831
+3% +$5.3M 0.15% 165
2013
Q4 		$180M Buy
1,592,534
+27,580
+2% +$2.49M 0.17% 150
2013
Q3 		$123M Buy
1,564,954
+147,846
+10% +$10.8M 0.12% 192
2013
Q2 		$93.3M Buy
+1,417,108
New +$91.3M 0.1% 219

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock Advisors's UTHR Position: Q4 2016 in Review

BlackRock Advisors increased its United Therapeutics (UTHR) stake by 9.1% in Q4 2016, buying an estimated $1.86M and bringing the position to 175,318 shares worth $25.1M. The position accounts for 0.03% of the portfolio, ranked #473.

BlackRock Advisors first reported a position in UTHR in Q2 2013 and has held it in 15 quarters since. The position peaked at $284M in Q1 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • BlackRock Advisors held 175,318 shares of United Therapeutics worth $25.1M as of Q4 2016.
  • BlackRock Advisors bought 14,572 United Therapeutics shares in Q4 2016, an estimated $1.86M.
  • United Therapeutics made up 0.03% of BlackRock Advisors's portfolio in Q4 2016, its #473 holding.
  • BlackRock Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's United Therapeutics position peaked at $284M in Q1 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.